Premium
Remission of Recalcitrant Epidermolysis Bullosa Acquisita (EBA) with Colchicine Monotherapy
Author(s) -
Arora Komal Pahuja,
Sachdeva Bharti,
Singh Navjeevan,
Bhattacharya Sambit Nath
Publication year - 2005
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/j.1346-8138.2005.tb00727.x
Subject(s) - epidermolysis bullosa acquisita , medicine , dapsone , colchicine , dermatology , prednisolone , dexamethasone , azathioprine , cyclophosphamide , tetracycline , surgery , chemotherapy , bullous pemphigoid , disease , immunology , antibiotics , biology , microbiology and biotechnology , antibody
A 42‐year‐old woman with widespread recalcitrant epidermolysis bullosa acquisita (EBA) responded well to colchicine monotherapy after attempts to control her disease with other modalities failed. These included dapsone, tetracycline, prednisolone, and combination of cyclophosphamide/azathioprine with dexamethasone ‘pulse therapy‘. The useful role of colchicine in controlling some difficult cases of EBA, a therapeutically problematic condition, is stressed.